Market Overview

Alnylam Pharma Reports Offering of $125M in Stock

Related ALNY
4 Biotechs Piper Jaffray Is Buying On The Pullback
Here's One Biotech Stock JMP Analysts Are Very Bullish On
Cholesterol Drug Data Good (Investor's Business Daily)

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY), a leading RNAi therapeutics company, today announced that it has commenced an underwritten public offering of shares of its common stock to raise aggregate proceeds of approximately $125 million. All of the shares in the offering are to be sold by Alnylam.

Posted-In: News Offerings


Related Articles (ALNY)

Get Benzinga's Newsletters